期刊文献+

免疫复合物致大鼠肺间质纤维化作用的研究 被引量:4

THE EFFECT OF PULMONARY FIBROSIS INDUCED BY IMMUNOCOMPLEX
下载PDF
导出
摘要 ①目的 探讨建立一种由免疫复合物 (IC)介导模拟特发性肺间质纤维化病变动物模型。②方法Wistar大鼠随机分为 3组 ,分别经气管内一次性注入生理盐水 (N组 )、博莱霉素 (B组 )、免疫复合物 (I组 )。第 7、1 4、2 8天处死动物 ,利用生化和组织病理等方法比较各组肺系数、羟脯氨酸 (HyP)含量及肺泡炎、纤维化的程度。③结果 第 7、1 4、2 8天时 ,I组肺组织肺系数均显著低于B组 (F =8.4 88~ 1 3.0 95 ,q =4 .0 5 2~ 5 .376 ,P <0 .0 5 ) ,与N组相比 ,差异无显著性 (q =1 .2 89~ 1 .739,P >0 .0 5 )。I组羟脯氨酸含量与N组相比差异显著 (F =1 7.6 91~31 .85 8,q =6 .5 83~ 1 0 .71 9,P <0 .0 5 )。I组肺泡炎及纤维化程度均较N组重 (F =6 .6 82~ 33.2 5 0 ,q =4 .2 84~7.5 92 ,P <0 .0 5 ) ,但轻于同期B组水平 (q =3.5 70~ 5 .1 1 6 ,P <0 .0 5 )。④结论 可以通过免疫复合物的介导建立肺间质纤维化模型。 Objective To study an idiopathic pulmonary fibrosis(IPF) model mediated by immuno-complex(IC). Methods Experimental Wistar rats were randomly divided into three groups: groups N, B, and I. Intratracheal injection of normal saline, bleomycin, and IC was done respectively for each group. The rats were killed on day 7, 14,and 28. Lung co-efficient, hydroxyproline, severity of alveolitis and fibrosis were compared between them by biochemical and pathological methods. Results Lung co-efficient and hydroxyproline in group I were significantly different from those in group B( F=8.488-13.095,q=4.052-5.376,P <0.05). The severity of alveolitis and fibrosis were also significantly increased in group I than those in group N( F= 6.682- 33.250,q=4.284-7.592,P <0.05). Conclusion An IPF model can be established by mediation of IC.
作者 胡晓玲
出处 《青岛大学医学院学报》 CAS 2004年第2期112-113,116,共3页 Acta Academiae Medicinae Qingdao Universitatis
关键词 肺纤维化 免疫复合物 博莱霉素 大鼠 pulmonary fibrosis immunocomplex bleomycin rats
  • 相关文献

参考文献9

  • 1[1]Robert JM, Marvin IS, Gray WH, et al. Pharmacological therapy for idiopathic pulmonary fibrosis[J]. Am J Respir Crit Care Med, 1999, 160:1771.
  • 2[2]International Consensus Statement. Idiopathic pulmonary fibrosis: diagnosis and treatment[J]. Am J Respir Crit Care Med, 2000,161:646.
  • 3[3]Susan VS, Norton AE, Jack DF, et al. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse[J]. American Review of Respiratory Disease, 1979, 120:893.
  • 4[4]Patrick GC, Alvaro R, Victor LR, et al. Pulmonary fibrogenesis after three consecutive inhalation exposures to chrysotile asbestos[J]. Am J Respir Crit Care Med, 1996,154:1511.
  • 5[5]Thomas JM, Jill DR, Robert PM, et al. Localization of type 1 procollagen gene expression in silica-induced grannlomatung disease and implication of transforming growth factor-β1 as a mediator of fibrosis[J]. Pathol, 1996,148(1):151.
  • 6[6]Denis M. Neutralization of transforming growth factor-betal in a mouse model of immune-induced lung fibrosis[J]. Immunology, 1994, 82:584.
  • 7[7]Roberts SN, Howie SEM, Wallance WAH, et al. A novel model for human interstitial lung disease: hapten-driven lung fibrosis in rodents[J]. J Pathol, 1995, 176(3):309.
  • 8[8]Mattew B, Theodore SH, Nai-san W, et al. CO2 and Nd:YAG laser-induced pulmonary parenchymal lung injury in a rabbit model[J]. Am J Respir Crit Care Med, 1996, 153:1136.
  • 9[9]Stephan WG, Thomas RK, Susan EW, et al. Transgenic models for study of pulmonary development and disease[J]. Am J Physiol, 1994,267(5pt1):L489.

同被引文献80

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部